This article is authored by Aditya Sharma, head, Process Solutions, India Region, Merck Life Science, New Delhi.

Cordyceps Sunshine Biotech Holdings Co., Ltd.【C.S Group】 announced a major milestone in veterinary drug development at the ...

Big pharmaceutical companies as well as smaller biotechs have been hoping to score a win in one of today's highest-growth ...

Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (AA) and other autoimmune and inflammatory diseases, ...

J INTS BIO, a company specializing in anticancer and orphan drugs, announced its research findings for the next-generation ...

The drug cytisinicline could help expand options for quitting smoking, and if approved by the FDA, would be the first new ...

The US Food and Drug Administration (FDA) has granted approval for AbbVie’s 15mg Rinvoq (upadacitinib) to treat adults with ...

Companies are developing myostatin inhibitors for GLP-1RA-related muscle loss, but some experts question their necessity.

At its April 2025 meeting, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) gave ...

Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its Interim Report January-March 2025. The full report is available on the Company's website. “Developmental intensity levels remain ...

Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...